CAREDIS
  • Home
  • About me
  • Your needs
  • Services
  • Business cases
  • Implementation
  • French Strategic Insights
  • Contact
  • LinkedIn
Select Page
Real-World Evidence in France: Why Registries Accelerate MedTech Reimbursement and Go-to-Market

Real-World Evidence in France: Why Registries Accelerate MedTech Reimbursement and Go-to-Market

by LMC | Jul 9, 2026 | Evidence generation, French strategic insights

When MedTech companies discuss real-world evidence (RWE), the conversation often focuses on collecting additional clinical data. In reality, real-world evidence in France supports reimbursement strategy, hospital adoption, physician engagement and go-to-market...
MedTech Go-to-Market in France: Direct Sales Team, Distributor, or Hybrid Model

MedTech Go-to-Market in France: Direct Sales Team, Distributor, or Hybrid Model

by LMC | Jul 1, 2026 | French strategic insights, Go to Market in France

Once reimbursement is secured—or at least clearly on the horizon—the next strategic question quickly emerges to improve MedTech Go-to-Market in France: Should we build a direct sales team in France or work with a distributor? At first glance, the answer may appear...
Procedure coding in France: The Most Overlooked Lever in MedTech Access

Procedure coding in France: The Most Overlooked Lever in MedTech Access

by LMC | Jun 24, 2026 | French strategic insights, Market access strategy

When international MedTech companies prepare their market access strategy in France, most discussions focus on clinical evidence, reimbursement pathways, pricing, and health technology assessment. However, one critical factor is frequently overlooked: procedure coding...
MedTech Market Entry in France: 3 Questions Every Company Should Ask Before Launch

MedTech Market Entry in France: 3 Questions Every Company Should Ask Before Launch

by LMC | Jun 16, 2026 | French strategic insights, Go to Market in France

When international MedTech companies prepare their market entry in France, the same questions tend to arise repeatedly. Do we need French clinical data? Should we meet the Haute Autorité de Santé (HAS) before launching a clinical study? Can we start selling before...
MedTech Reimbursement in France: Why the Right Pathway Matters More Than the Data

MedTech Reimbursement in France: Why the Right Pathway Matters More Than the Data

by LMC | Jun 9, 2026 | French strategic insights, Reimbursement Strategy

One of the most common questions asked by emerging MedTech companies is: “What clinical data do we need for reimbursement in France?” At first glance, the question seems logical. However, it is often the wrong starting point. In fact, successful MedTech reimbursement...
« Older Entries
  • Follow

Your Go to Market Partner in France

MARKET access-marketing

  • Home
  • About me
  • Your needs
  • Services
  • Business cases
  • Implementation
  • French Strategic Insights


connectme@caredis.fr

Book an Appointment Today!

2023- Copyrights CAREDIS-Design by CABYACT

Legal Notice – Privacy Policy – Cookie Policy

Would you like a little cookie?


We wait to be sure that the content of this site interests you before disturbing, but we would like to accompany you during your visit. Is that okay with you? Not consenting or withdrawing consent can have a negative effect on certain features and functions.
Fonctionnel Always active
Le stockage ou l’accès technique est strictement nécessaire dans la finalité d’intérêt légitime de permettre l’utilisation d’un service spécifique explicitement demandé par l’abonné ou l’utilisateur, ou dans le seul but d’effectuer la transmission d’une communication sur un réseau de communications électroniques.
Préférences
Le stockage ou l’accès technique est nécessaire dans la finalité d’intérêt légitime de stocker des préférences qui ne sont pas demandées par l’abonné ou la personne utilisant le service.
Statistiques
Le stockage ou l’accès technique qui est utilisé exclusivement à des fins statistiques. Le stockage ou l’accès technique qui est utilisé exclusivement dans des finalités statistiques anonymes. En l’absence d’une assignation à comparaître, d’une conformité volontaire de la part de votre fournisseur d’accès à internet ou d’enregistrements supplémentaires provenant d’une tierce partie, les informations stockées ou extraites à cette seule fin ne peuvent généralement pas être utilisées pour vous identifier.
Marketing
Le stockage ou l’accès technique est nécessaire pour créer des profils d’utilisateurs afin d’envoyer des publicités, ou pour suivre l’utilisateur sur un site web ou sur plusieurs sites web ayant des finalités marketing similaires.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
See preferences
  • {title}
  • {title}
  • {title}